Skip to content
DefenceGate

FP7

GETREAL

Incorporating real-life clinical data into drug development

Programme
Seventh Framework Programme
Started
Ends
Duration
42 months
Total cost
EUR 16,952,280
EU contribution
EUR 8,000,000
Participants
29 from 10 countries
Topic
FP7_IMI-JU-07-2012-02
Grant agreement
115546

Coordinated by Glaxosmithkline Research & Development Limited (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Glaxosmithkline Research & Development LimitedGBUnited KingdomCoordinatorNot statedPIC (1.00)
AmgenBEBelgiumParticipantNot statedPIC (1.00)
European Organisation for Research and Treatment of Cancer AisblBEBelgiumParticipantEUR 269,500PIC (1.00)
Janssen Pharmaceutica NVBEBelgiumParticipantNot statedPIC (1.00)
Novartis Pharma AGCHSwitzerlandParticipantNot statedPIC (1.00)
Universitaet BernCHSwitzerlandParticipantEUR 1,430,140PIC (1.00)
Bayer Pharma AGDEGermanyParticipantNot statedPIC (1.00)
Boehringer Ingelheim InternationalgmbhDEGermanyParticipantNot statedPIC (1.00)
Merck KGaADEGermanyParticipantNot statedPIC (1.00)
Novo Nordisk A/SDKDenmarkParticipantNot statedPIC (1.00)
Haute Autorite de SanteFRFranceParticipantEUR 269,170known name (0.95)
L.A Sante, Epidemiologie, Evaluation et Recherche L.A.S.E.R.FRFranceParticipantEUR 860,242PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantNot statedPIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantNot statedPIC (1.00)
International Alliance of Patient'organizationsGBUnited KingdomParticipantEUR 125,128PIC (1.00)
International Alliance of Patients’ OrganizationsGBUnited KingdomParticipantNot statedPIC (1.00)
London School of Hygiene and Tropical Medicine Royal CharterGBUnited KingdomParticipantNot statedPIC (1.00)
National Institute for Health and Care ExcellenceGBUnited KingdomParticipantEUR 1,058,742known name (0.95)
Takeda Development Centre Europe LtdGBUnited KingdomParticipantNot statedPIC (1.00)
The University of ManchesterGBUnited KingdomParticipantEUR 225,786known name (0.95)
University of LeicesterGBUnited KingdomParticipantEUR 464,447known name (0.95)
Panepistimio IoanninonGRGreeceParticipantEUR 97,050PIC (1.00)
Academisch Ziekenhuis GroningenNLNetherlandsParticipantEUR 615,260PIC (1.00)
The European Medicines AgencyNLNetherlandsParticipantEUR 117,501PIC (1.00)
Universitair Medisch Centrum UtrechtNLNetherlandsParticipantEUR 2,270,934known name (0.95)
Zorginstituut NederlandNLNetherlandsParticipantEUR 196,100known name (0.95)
Astrazeneca ABSESwedenParticipantNot statedPIC (1.00)
Bristol-Myers Squibb Company CorpUSUnited StatesParticipantNot statedPIC (1.00)
Merck Sharp & Dohme CorpUSUnited StatesParticipantNot statedPIC (1.00)

Changes of the consortium

First seen on with 29 participants from 10 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.